0,928  0,003  CYP1A2 inhibitor
0,926  0,002  Antimutagenic
0,919  0,002  Caspase 9 stimulant
0,866  0,003  AR expression inhibitor
0,872  0,009  Apoptosis agonist
0,852  0,004  Free radical scavenger
0,837  0,004  Antioxidant
0,830  0,004  UGT1A6 substrate
0,820  0,002  Cystathionine beta-synthase inhibitor
0,819  0,004  NOS2 expression inhibitor
0,814  0,004  UGT1A9 substrate
0,814  0,004  12-Lipoxygenase inhibitor
0,813  0,004  CTGF expression inhibitor
0,804  0,009  Antineoplastic (breast cancer)
0,793  0,005  Chemoprotective
0,786  0,007  Antileukemic
0,776  0,010  Antineoplastic (lung cancer)
0,768  0,005  Prostate cancer treatment
0,758  0,005  Caspase 3 stimulant
0,741  0,005  Cardioprotectant
0,733  0,003  UGT1A3 substrate
0,736  0,008  Chemopreventive
0,724  0,007  Aldehyde oxidase inhibitor
0,721  0,005  Antineoplastic (cervical cancer)
0,734  0,028  Alpha-glucosidase inhibitor
0,717  0,011  15-Lipoxygenase inhibitor
0,710  0,008  CYP1A2 substrate
0,704  0,005  UGT1A1 substrate
0,702  0,005  Lipoxygenase inhibitor
0,692  0,005  Amyloid beta aggregation inhibitor
0,697  0,021  Transcription factor NF kappa B inhibitor
0,677  0,003  NADPH oxidase inhibitor
0,676  0,003  Peroxidase inhibitor
0,683  0,015  TNF expression inhibitor
0,683  0,016  Antineoplastic (colorectal cancer)
0,671  0,016  Antineoplastic (colon cancer)
0,655  0,003  UGT2B15 substrate
0,651  0,005  UDP-glucuronosyltransferase substrate
0,649  0,005  Genotoxic
0,645  0,005  Tubulin antagonist
0,648  0,009  Cytostatic
0,638  0,004  Breast cancer-resistant protein inhibitor
0,636  0,006  Vasodilator, coronary
0,633  0,004  P-glycoprotein inhibitor
0,630  0,005  Superoxide dismutase inhibitor
0,618  0,003  Carbonic anhydrase XIII inhibitor
0,621  0,010  Proliferative diseases treatment
0,615  0,009  Histamine release inhibitor
0,613  0,008  CYP2C19 inhibitor
0,608  0,003  Xanthine oxidase inhibitor
0,613  0,009  Antineoplastic (non-small cell lung cancer)
0,606  0,008  Ulceration
0,636  0,044  Antiinflammatory
0,593  0,005  Monophenol monooxygenase inhibitor
0,607  0,020  CYP2C9 substrate
0,585  0,009  Antiprotozoal (Leishmania)
0,587  0,014  Antineoplastic (melanoma)
0,581  0,010  GABA C receptor rho-3 antagonist
0,574  0,005  Skin whitener
0,571  0,008  Antineoplastic (osteosarcoma)
0,578  0,016  Radioprotector
0,572  0,010  Antineoplastic (glioma)
0,563  0,004  Amylase inhibitor
0,563  0,005  MAO A inhibitor
0,564  0,006  Antihypoxic
0,559  0,007  Antihypertriglyceridemic
0,559  0,014  NOS3 expression inhibitor
0,548  0,005  Antineoplastic (squamous cell carcinoma)
0,561  0,019  Antineoplastic (ovarian cancer)
0,551  0,010  DNA damaging
0,550  0,010  Hypoxia-inducible factor 1 alpha inhibitor
0,547  0,009  Vascular (periferal) disease treatment
0,528  0,010  Antineoplastic (glioblastoma multiforme)
0,527  0,010  Vasodilator
0,535  0,018  CYP2C9 inhibitor
0,529  0,014  Nitric oxide antagonist
0,533  0,019  Spasmolytic
0,518  0,011  Antimitotic
0,512  0,007  MAO inhibitor
0,517  0,013  Tumour necrosis factor alpha release inhibitor
0,518  0,018  Apoptosis antagonist
0,531  0,035  Prostaglandin dehydrogenase inhibitor
0,501  0,009  Antineoplastic (carcinoma)
0,500  0,009  Pyruvate kinase inhibitor
0,505  0,014  Cardiodepressant
0,512  0,023  Aryl hydrocarbon receptor agonist
0,495  0,007  Antiseptic
0,498  0,012  ICAM1 expression inhibitor
0,487  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,492  0,012  UGT2B4 substrate
0,491  0,011  RNA-directed DNA polymerase inhibitor
0,494  0,016  Antiamyloidogenic
0,504  0,027  CYP2C19 substrate
0,499  0,022  Hepatic disorders treatment
0,495  0,020  Antineoplastic (brain cancer)
0,495  0,020  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,478  0,003  Antihemorrhagic
0,480  0,008  Hepatoprotectant
0,501  0,032  5 Hydroxytryptamine release inhibitor
0,470  0,006  Lipid peroxidase inhibitor
0,463  0,008  Topoisomerase II inhibitor
0,478  0,024  Antineoplastic (pancreatic cancer)
0,474  0,023  Mutagenic
0,454  0,005  Pneumotoxic
0,453  0,009  Melanin inhibitor
0,445  0,008  5 Hydroxytryptamine uptake stimulant
0,447  0,010  Dual specificity phosphatase inhibitor
0,446  0,010  Dual specificity phosphatase 3 inhibitor
0,466  0,031  Antihypercholesterolemic
0,437  0,004  SULT1A3 substrate
0,432  0,004  Carbonic anhydrase III inhibitor
0,448  0,021  Hypoglycemic
0,469  0,043  Antipruritic, allergic
0,430  0,015  Antineoplastic (small cell lung cancer)
0,432  0,018  Antineoplastic (liver cancer)
0,418  0,007  Protein kinase stimulant
0,439  0,028  Carcinogenic
0,411  0,005  Topoisomerase II alpha inhibitor
0,409  0,003  Creatine kinase inhibitor
0,407  0,006  Acetylcholinesterase inhibitor
0,401  0,005  Interleukin 4 antagonist
0,400  0,005  Alkaline phosphatase inhibitor
0,402  0,009  DNA methyltransferase I inhibitor
0,393  0,003  Antihelmintic (Trematoda)
0,416  0,028  Cardiovascular analeptic
0,392  0,004  Aldose reductase inhibitor
0,401  0,016  Antineoplastic (sarcoma)
0,396  0,012  Antihypotensive
0,392  0,009  Protein-tyrosine phosphatase inhibitor
0,422  0,039  FMO1 substrate
0,385  0,004  Nitric-oxide synthase stimulant
0,381  0,004  Carbonic anhydrase VI inhibitor
0,384  0,009  Antineoplastic (gastric cancer)
0,382  0,009  NOS3 expression enhancer
0,379  0,006  M18 aspartyl aminopeptidase inhibitor
0,377  0,004  Gastritis treatment
0,434  0,063  Antibacterial
0,374  0,005  Gout treatment
0,423  0,057  CYP3A4 substrate
0,463  0,097  DNA polymerase beta inhibitor
0,372  0,006  5-Lipoxygenase inhibitor
0,383  0,017  UGT1A4 substrate
0,411  0,046  Bone diseases treatment
0,400  0,036  Cytotoxic
0,387  0,027  Antineoplastic (renal cancer)
0,364  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,381  0,023  Antineoplastic enhancer
0,372  0,017  GST M1-1 substrate
0,416  0,062  Antiprotozoal
0,392  0,039  Antiosteoporotic
0,356  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,349  0,003  Xanthine dehydrogenase inhibitor
0,361  0,015  DNA methylase inhibitor
0,350  0,004  Beta tubulin antagonist
0,341  0,003  Multidrug resistance-associated protein 1 inhibitor
0,369  0,034  Antipyretic
0,342  0,009  Sulfotransferase substrate
0,431  0,104  DNA directed DNA polymerase inhibitor
0,362  0,037  Radiosensitizer
0,324  0,004  Alpha tubulin antagonist
0,357  0,040  Antineoplastic (multiple myeloma)
0,320  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,333  0,020  UGT2B7 substrate
0,317  0,005  Beta glucuronidase inhibitor
0,345  0,034  Antiparasitic
0,336  0,025  Antihelmintic
0,314  0,004  VEGF expression inhibitor
0,349  0,040  Antiprotozoal (Trypanosoma)
0,344  0,036  Transcription factor STAT inhibitor
0,316  0,010  Chelator
0,326  0,023  Non-steroidal antiinflammatory agent
0,317  0,015  Tumour necrosis factor antagonist
0,356  0,055  5 Hydroxytryptamine release stimulant
0,345  0,044  Sensitization
0,341  0,040  Antineoplastic (lymphoma)
0,315  0,014  CYP2B6 inhibitor
0,337  0,039  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,298  0,006  Telomerase inhibitor
0,313  0,022  VCAM1 expression inhibitor
0,306  0,016  Amyloid beta precursor protein antagonist
0,295  0,005  SULT1A1 substrate
0,298  0,011  UGT2B9 substrate
0,305  0,018  Cholinergic
0,323  0,036  Antineoplastic (lymphocytic leukemia)
0,313  0,027  Tyrosine 3 hydroxylase inhibitor
0,341  0,056  CYP3A4 inhibitor
0,294  0,008  Carbonic anhydrase XV inhibitor
0,316  0,036  Antineoplastic (bladder cancer)
0,305  0,029  Antiviral (Influenza)
0,307  0,032  Platelet adhesion inhibitor
0,291  0,016  Antidote
0,357  0,083  Immunosuppressant
0,276  0,008  GABA C receptor rho-2 antagonist
0,337  0,069  Antithrombotic
0,279  0,012  LDLR expression enhancer
0,310  0,045  Angiogenesis stimulant
0,330  0,066  CYP2D6 substrate
0,275  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,270  0,008  Mannose-6-phosphate isomerase inhibitor
0,329  0,068  Antifungal
0,304  0,051  Dyrk kinase inhibitor
0,277  0,024  Carcinogenic, group 3
0,269  0,017  Succinate dehydrogenase inhibitor
0,267  0,017  Glutathione S-transferase substrate
0,252  0,004  CDC25A inhibitor
0,267  0,022  Bone formation stimulant
0,259  0,021  Hemostatic
0,250  0,013  UGT2B10 substrate
0,288  0,054  Myocardial infarction treatment
0,261  0,028  Insulin sensitizer
0,249  0,017  MAO B inhibitor
0,237  0,006  Antineoplastic (uterine cancer)
0,251  0,020  Antineoplastic (bone cancer)
0,235  0,005  Histone deacetylase SIRT1 stimulant
0,235  0,005  Histone deacetylase stimulant
0,261  0,032  Mcl-1 antagonist
0,256  0,027  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,317  0,089  Antiprotozoal (Plasmodium)
0,238  0,011  Toll-Like receptor 2 antagonist
0,235  0,008  Protein kinase C zeta inhibitor
0,243  0,019  Carcinogenic, group 1
0,227  0,004  Carbonic anhydrase VII inhibitor
0,229  0,008  AMP-activated protein kinase stimulant
0,280  0,060  Antidiabetic symptomatic
0,232  0,017  Butyrylcholinesterase inhibitor
0,225  0,012  Cyclooxygenase 3 inhibitor
0,236  0,025  Heat shock protein 90 antagonist
0,328  0,122  Antiparkinsonian
0,208  0,003  D-Ala-D-Ala ligase inhibitor
0,208  0,005  Heat shock protein 70 antagonist
0,287  0,085  Streptokinase A inhibitor
0,214  0,014  UGT2B1 substrate
0,220  0,022  Topoisomerase I inhibitor
0,206  0,008  Electron transport complex I inhibitor
0,240  0,044  Neurotrophic factor enhancer
0,207  0,012  Histidine decarboxylase inhibitor
0,266  0,072  Transcription factor STAT3 inhibitor
0,206  0,012  Uric acid excretion stimulant
0,200  0,007  DOPA decarboxylase inhibitor
0,223  0,033  Antiviral (Influenza A)
0,251  0,063  Cyclic AMP phosphodiesterase inhibitor
0,219  0,034  Cyclooxygenase inhibitor
0,189  0,005  Antifungal (Pneumocystis)
0,189  0,005  HIV-1 integrase inhibitor
0,186  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,215  0,033  Interleukin 6 antagonist
0,294  0,114  GST A substrate
0,200  0,020  Expectorant
0,190  0,010  Estrogen receptor beta antagonist
0,210  0,030  Cyclooxygenase 1 inhibitor
0,254  0,075  Teratogen
0,216  0,037  Antiviral (Ebola)
0,189  0,011  Urease inhibitor
0,189  0,014  Estrogen antagonist
0,182  0,009  Macrophage migration inhibitory factor inhibitor
0,239  0,066  Interleukin antagonist
0,203  0,034  Phobic disorders treatment
0,315  0,149  Cyclophilin D inhibitor
0,315  0,149  Antidiabetic
0,192  0,029  Alkylator
0,259  0,097  Respiratory analeptic
0,170  0,008  Myeloperoxidase inhibitor
0,171  0,011  Aromatase inhibitor
0,167  0,007  Thioredoxin reductase inhibitor
0,258  0,099  Antiischemic
0,186  0,027  Protein kinase (CK2) alpha inhibitor
0,176  0,018  Papain-like protease (SARS coronavirus) inhibitor
0,194  0,038  Cytokine production inhibitor
0,188  0,035  Cyclooxygenase 2 inhibitor
0,164  0,012  SULT1E1 substrate
0,224  0,072  Antiulcerative
0,272  0,122  Calcium channel activator
0,172  0,024  Choleretic
0,154  0,006  CDC25B inhibitor
0,157  0,013  Antiviral (SARS coronavirus)
0,157  0,013  Antiviral (Coronavirus)
0,153  0,010  T cell inhibitor
0,166  0,022  Mediator release inhibitor
0,148  0,005  Fatty acid synthase inhibitor
0,244  0,102  Insulysin inhibitor
0,194  0,053  Heat shock protein 90 alpha antagonist
0,147  0,006  Estradiol 17 beta-dehydrogenase inhibitor
0,210  0,069  Anesthetic general
0,257  0,117  Antiallergic
0,304  0,164  Alzheimer's disease treatment
0,171  0,032  Antibacterial (Helicobacter pylori)
0,186  0,048  Arachidonic acid antagonist
0,149  0,011  Interleukin 5 antagonist
0,162  0,025  Photosensitizer
0,220  0,083  Embryotoxic
0,183  0,046  Insulin secretagoues
0,160  0,024  DNA repair enzyme inhibitor
0,144  0,012  Estrogen receptor alpha antagonist
0,151  0,021  GABA C receptor rho-1 antagonist
0,145  0,015  Cyclin B3 inhibitor
0,199  0,071  Histone acetyltransferase inhibitor
0,172  0,045  CF transmembrane conductance regulator agonist
0,178  0,052  Interferon gamma antagonist
0,143  0,018  UGT2B11 substrate
0,141  0,017  Carbonic anhydrase V inhibitor
0,128  0,004  Catechol O-methyltransferase inhibitor
0,184  0,061  Antirickettsial
0,162  0,039  Antitussive
0,190  0,068  Antiviral (Hepatitis)
0,246  0,126  Thyroid hormone antagonist
0,212  0,092  Antiviral (West Nile virus)
0,123  0,004  Transcription factor RelA inhibitor
0,188  0,069  Antipruritic, non-allergic
0,233  0,115  Analeptic
0,149  0,031  Antineoplastic antibiotic
0,144  0,028  Transcription factor STAT6 inhibitor
0,239  0,126  Thyroid hormone beta antagonist
0,128  0,016  Carbonic anhydrase VA inhibitor
0,125  0,013  Estrogen agonist
0,141  0,029  Dementia treatment
0,155  0,044  Aldehyde dehydrogenase inhibitor
0,139  0,028  Toll-Like receptor 4 antagonist
0,116  0,006  Potassium channel Kv1.3 blocker
0,145  0,035  Mucolytic
0,133  0,024  Thioredoxin inhibitor
0,149  0,040  Coagulant
0,119  0,012  Neuraminidase (influenza) inhibitor
0,159  0,052  Antifungal enhancer
0,124  0,016  Lipase inhibitor
0,145  0,038  Contraceptive female
0,158  0,051  Adenylate cyclase stimulant
0,135  0,029  Vascular dementia treatment
0,116  0,011  Neuraminidase inhibitor
0,177  0,073  Male reproductive disfunction treatment
0,160  0,057  Antiprotozoal (Coccidial)
0,169  0,066  Antiviral (Hepatitis C)
0,143  0,042  Carcinogenic, group 2B
0,129  0,029  Alcohol dehydrogenase inhibitor
0,132  0,033  HIV-1 integrase (Overall Integration) inhibitor
0,184  0,085  Abortion inducer
0,104  0,005  Postcoital contraceptive
0,138  0,039  Antiviral (Influenza B)
0,107  0,008  Glutamate (mGluR7) antagonist
0,119  0,020  Dopamine agonist
0,119  0,022  Keratolytic
0,136  0,039  Protein kinase (CK2) inhibitor
0,110  0,013  Antidote, heavy metal
0,120  0,029  Interleukin 12 antagonist
0,097  0,007  Glucose-6-phosphate translocase inhibitor
0,132  0,042  GABA C receptor antagonist
0,094  0,005  GABA B receptor antagonist
0,167  0,078  3C-like protease (Human coronavirus) inhibitor
0,111  0,023  Granulocyte macrophage colony stimulating factor agonist
0,097  0,015  Aryl hydrocarbon receptor antagonist
0,151  0,070  Antidiarrheal
0,124  0,043  GST P1-1 substrate
0,123  0,044  Anticataract
0,132  0,053  Retinopathy treatment
0,162  0,084  Phospholipase C inhibitor
0,199  0,121  Immunostimulant
0,091  0,013  Carbonic anhydrase XIV inhibitor
0,085  0,007  Ryanodine receptor antagonist
0,088  0,010  CD45 antagonist
0,081  0,006  Dopamine D5 agonist
0,086  0,012  Topoisomerase II beta inhibitor
0,130  0,057  Cholesterol synthesis inhibitor
0,092  0,019  Postmenopausal disorders treatment
0,116  0,044  Sphingomyelinase inhibitor
0,090  0,020  Protein kinase C eta inhibitor
0,219  0,149  Cholesterol antagonist
0,088  0,019  Protease activated receptor antagonist
0,122  0,056  DNA intercalator
0,276  0,211  Antineoplastic (solid tumors)
0,223  0,158  Sodium/bile acid cotransporter inhibitor
0,093  0,030  Leukotriene synthesis inhibitor
0,097  0,035  Na+ K+ transporting ATPase inhibitor
0,143  0,084  Antiviral (Herpes)
0,098  0,039  Antiviral (Hepatitis A)
0,109  0,051  Antifungal (Aspergillus)
0,193  0,134  Antituberculosic
0,204  0,146  Antimycobacterial
0,119  0,061  Microtubule formation inhibitor
0,138  0,082  Ca2+-transporting ATPase inhibitor
0,100  0,045  Ornithine decarboxylase inhibitor
0,214  0,160  Vasodilator, peripheral
0,060  0,012  Neuraminidase (Influenza A) inhibitor
0,055  0,007  Nucleoside transporters inhibitor
0,125  0,077  Toll-Like receptor antagonist
0,092  0,045  Glutathione S-transferase inhibitor
0,158  0,111  I kappa B kinase epsilon inhibitor
0,090  0,046  mTOR complex 2 inhibitor
0,095  0,051  Calcium antagonist
0,059  0,015  Estrogen receptor alpha agonist
0,047  0,005  Dopamine D1 agonist
0,169  0,127  Antiviral (HIV)
0,070  0,029  Carbonic anhydrase XII inhibitor
0,074  0,036  Dopamine D1 antagonist
0,067  0,030  Maillard reaction inhibitor
0,103  0,066  HDL-cholesterol increasing
0,091  0,054  Androgen antagonist
0,044  0,008  Estrogen-related receptor beta antagonist
0,057  0,021  Dopamine D5 antagonist
0,050  0,015  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,095  0,060  Prolactin inhibitor
0,084  0,051  Arylamine N-Acetyltransferase substrate
0,040  0,009  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,050  0,019  Estrogen receptor beta agonist
0,116  0,085  Antihyperlipoproteinemic
0,086  0,056  Phosphodiesterase IV inhibitor
0,055  0,024  Dopamine D2 agonist
0,077  0,047  Adenosine A3 receptor antagonist
0,067  0,038  Beta 3 adrenoreceptor antagonist
0,065  0,037  Transcription factor AP-1 inhibitor
0,061  0,034  Carbonic anhydrase VB inhibitor
0,077  0,050  Antitreponemal
0,125  0,099  Skeletal muscle relaxant
0,095  0,070  Alpha 2c adrenoreceptor antagonist
0,083  0,058  Estrogen-related receptor beta agonist
0,098  0,074  Antiprotozoal (Toxoplasma)
0,070  0,047  Elastase 1 inhibitor
0,128  0,104  Phospholipase A2 inhibitor
0,037  0,015  Protein kinase (CK2) beta inhibitor
0,130  0,109  Muscle relaxant
0,065  0,044  Leukotriene antagonist
0,052  0,031  Squalene epoxidase inhibitor
0,085  0,065  NADH dehydrogenase inhibitor
0,225  0,205  Transcription factor inhibitor
0,132  0,113  Liver fibrosis treatment
0,117  0,098  Acaricide
0,093  0,074  Anabolic
0,080  0,062  Inducible nitric-oxide synthase inhibitor
0,071  0,054  Phosphodiesterase 4D inhibitor
0,118  0,100  Psychosexual dysfunction treatment
0,039  0,023  Arginase inhibitor
0,156  0,139  Antialcoholic
0,100  0,085  Nav1.5 sodium channel blocker
0,138  0,124  Aldehyde oxidase substrate
0,083  0,069  Antidote, mercury
0,074  0,059  Narcotic antagonist
0,058  0,044  Heat shock protein 90 beta antagonist
0,063  0,050  Beta adrenoreceptor antagonist
0,033  0,021  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,192  0,180  FMO3 substrate
0,071  0,060  GABA aminotransferase inhibitor
0,094  0,083  Antihelmintic (Fasciola)
0,071  0,060  Phosphodiesterase VI inhibitor
0,052  0,041  Leukotriene B4 antagonist
0,086  0,076  Antiviral (Rhinovirus)
0,059  0,050  Phosphodiesterase 1C inhibitor
0,112  0,104  Hair growth stimulant
0,050  0,045  Alcohol oxidase inhibitor
0,065  0,060  SULT2A1 substrate
0,145  0,141  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,047  0,043  CXC chemokine 1 receptor antagonist
0,020  0,017  Estrone sulfatase inhibitor
0,053  0,050  Leukotriene C antagonist
0,029  0,026  ATP citrate lysase inhibitor
0,109  0,107  Antiprotozoal (Trichomonas)
0,054  0,053  Cyclin D1 inhibitor
0,080  0,079  Actinic keratosis treatment
0,063  0,063  Anticholelithogenic

